GB201719393D0 - Pyrrolobenzodiazepine-antibody conjugates - Google Patents

Pyrrolobenzodiazepine-antibody conjugates

Info

Publication number
GB201719393D0
GB201719393D0 GBGB1719393.9A GB201719393A GB201719393D0 GB 201719393 D0 GB201719393 D0 GB 201719393D0 GB 201719393 A GB201719393 A GB 201719393A GB 201719393 D0 GB201719393 D0 GB 201719393D0
Authority
GB
United Kingdom
Prior art keywords
pyrrolobenzodiazepine
antibody conjugates
conjugates
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1719393.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1719393.9A priority Critical patent/GB201719393D0/en
Publication of GB201719393D0 publication Critical patent/GB201719393D0/en
Priority to NZ754811A priority patent/NZ754811A/en
Priority to PL18706437T priority patent/PL3579883T3/en
Priority to MX2019009427A priority patent/MX375568B/en
Priority to SI201830452T priority patent/SI3579883T1/en
Priority to EA202091705A priority patent/EA202091705A1/en
Priority to HUE18706437A priority patent/HUE056289T2/en
Priority to EP18706437.3A priority patent/EP3579883B1/en
Priority to PT187064373T priority patent/PT3579883T/en
Priority to JP2019542213A priority patent/JP6704532B1/en
Priority to SM20220068T priority patent/SMT202200068T1/en
Priority to PCT/EP2018/053188 priority patent/WO2018146199A1/en
Priority to CN201880009386.9A priority patent/CN110300601B/en
Priority to CA3047686A priority patent/CA3047686C/en
Priority to KR1020197023786A priority patent/KR102153642B1/en
Priority to EP21182172.3A priority patent/EP3939616A1/en
Priority to US16/484,313 priority patent/US11384098B2/en
Priority to DK18706437.3T priority patent/DK3579883T3/en
Priority to HRP20211640TT priority patent/HRP20211640T1/en
Priority to ES18706437T priority patent/ES2890934T3/en
Priority to AU2018219654A priority patent/AU2018219654B2/en
Priority to UAA202004636A priority patent/UA123889C2/en
Priority to RS20211152A priority patent/RS62343B1/en
Priority to LTEPPCT/EP2018/053188T priority patent/LT3579883T/en
Priority to BR112019016420A priority patent/BR112019016420A2/en
Priority to ZA2019/04269A priority patent/ZA201904269B/en
Priority to CY20211100915T priority patent/CY1124714T1/en
Priority to US17/805,331 priority patent/US20230053603A1/en
Ceased legal-status Critical Current

Links

GBGB1719393.9A 2017-02-08 2017-11-22 Pyrrolobenzodiazepine-antibody conjugates Ceased GB201719393D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB1719393.9A GB201719393D0 (en) 2017-11-22 2017-11-22 Pyrrolobenzodiazepine-antibody conjugates
BR112019016420A BR112019016420A2 (en) 2017-02-08 2018-02-08 pyrrolobenzodiazepine-antibody conjugates
CN201880009386.9A CN110300601B (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
KR1020197023786A KR102153642B1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugate
MX2019009427A MX375568B (en) 2017-02-08 2018-02-08 PYRROLOBENZODIAZEPINES AND ANTIBODIES CONJUGATES
SI201830452T SI3579883T1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
EA202091705A EA202091705A1 (en) 2017-11-22 2018-02-08 PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
HUE18706437A HUE056289T2 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine antibody conjugates
EP18706437.3A EP3579883B1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
PT187064373T PT3579883T (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
JP2019542213A JP6704532B1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine antibody complex
SM20220068T SMT202200068T1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
PCT/EP2018/053188 WO2018146199A1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
NZ754811A NZ754811A (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
CA3047686A CA3047686C (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
PL18706437T PL3579883T3 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
EP21182172.3A EP3939616A1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
US16/484,313 US11384098B2 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
DK18706437.3T DK3579883T3 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
HRP20211640TT HRP20211640T1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
ES18706437T ES2890934T3 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine and antibody conjugates
AU2018219654A AU2018219654B2 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
UAA202004636A UA123889C2 (en) 2017-02-08 2018-02-08 PYROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
RS20211152A RS62343B1 (en) 2017-02-08 2018-02-08 Pyrrolobenzodiazepine-antibody conjugates
LTEPPCT/EP2018/053188T LT3579883T (en) 2017-02-08 2018-02-08 PYROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
ZA2019/04269A ZA201904269B (en) 2017-02-08 2019-06-28 Pyrrolobenzodiazepine-antibody conjugates
CY20211100915T CY1124714T1 (en) 2017-02-08 2021-10-21 PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
US17/805,331 US20230053603A1 (en) 2017-02-08 2022-06-03 Pyrrolobenzodiazepine-antibody conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1719393.9A GB201719393D0 (en) 2017-11-22 2017-11-22 Pyrrolobenzodiazepine-antibody conjugates

Publications (1)

Publication Number Publication Date
GB201719393D0 true GB201719393D0 (en) 2018-01-03

Family

ID=60805724

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1719393.9A Ceased GB201719393D0 (en) 2017-02-08 2017-11-22 Pyrrolobenzodiazepine-antibody conjugates

Country Status (2)

Country Link
EA (1) EA202091705A1 (en)
GB (1) GB201719393D0 (en)

Also Published As

Publication number Publication date
EA202091705A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
IL285516B (en) Amatoxin-antibody conjugates
ZA201904269B (en) Pyrrolobenzodiazepine-antibody conjugates
SI3592393T1 (en) Releasable conjugates
PT3544636T (en) Pyrrolobenzodiazepine-antibody conjugates
GB201702031D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201513607D0 (en) Pyrrolobenzodiazepine-antibody conjugates
IL272625A (en) Pyrrolobenzodiazepine conjugates
IL269945B (en) Pyrrolobenzodiazepine conjugates
GB201820626D0 (en) Conjugates
PT3270711T (en) Sugar-dipeptide conjugates
GB201712824D0 (en) Multi-functionalized nOMV Conjugates
SG10201506686WA (en) Conjugates
GB201721290D0 (en) Conjugates
GB201719906D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201719393D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201719398D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201719391D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201706466D0 (en) pyrrolobenzodiazepine-peptide conjugates
GB201702029D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201811332D0 (en) Pyrroloobenzodiazepine-antibody conjugates
GB201811335D0 (en) Pyrrolobenzodiazepine-antibody conjugates
GB201721337D0 (en) Pyrrolobenzodiazepine conjugates
GB201518839D0 (en) Conjugates
GB201705290D0 (en) Improvements
GB201513605D0 (en) Pyrrolobenzodiazepine-antibody conjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)